Miahelsa HoldingsTSE:7129 -0.69%44 Days Payable is 40.16 as of Mar. 2026, which is 5% below its 10-year median of 42.40. GuruFocus rates TSE:7129 with a GF Score™ of 44/100 and a GF Value™ of 円1,071.08 (Fairly Valued). The stock has 3 warning signs investors should review. Among 605 Healthcare Providers & Services companies, Miahelsa Holdings ranks worse than 64.3% on this metric.
The historical rank and industry rank for Miahelsa Holdings's Days Payable or its related term are showing as below:
TSE:7129'
s Days Payable Range Over the Past 10 Years
Min: 40.74 Med: 42.4 Max: 48.8
Current: 40.74
During the past 5 years, Miahelsa Holdings's highest Days Payable was 48.80. The lowest was 40.74. And the median was 42.40.
TSE:7129's Days Payable is ranked worse than 64.3% of 605
companies
in the Healthcare Providers & Services industry
Industry Median: 57.51
vs TSE:7129: 40.74
Miahelsa Holdings's Days Payable
increased
from Mar. 2025 (40.12) to Mar. 2026 (40.16).
It may suggest that Miahelsa Holdingsdelayed paying its suppliers.
Miahelsa Holdings Days Payable Related Terms
Miahelsa Holdings Days Payable Historical Data
* Premium members only.
The historical data trend for Miahelsa Holdings's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Miahelsa Holdings Days Payable Competitor Comparison
For the Pharmaceutical Retailers subindustry, Miahelsa Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Miahelsa Holdings Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Miahelsa Holdings's Days Payable distribution charts can be found below:
* The bar in red indicates where Miahelsa Holdings's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Miahelsa Holdings's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Miahelsa Holdings (TSE:7129) has a Days Payable of 40.16 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Miahelsa Holdings and its competitors. This is near median its historical median of 42.40. Over the past decade, Miahelsa Holdings' Days Payable has ranged from 40.74 to 48.80. According to the industry distribution chart, Miahelsa Holdings ranks #389 out of 605 companies in the Healthcare Providers & Services industry, placing it in the top 64.3%.
Is Miahelsa Holdings' Days Payable too high?
Miahelsa Holdings' current Days Payable of 40.16 is near median its 10-year median of 42.40. Over the past 10 years, this metric has ranged from a low of 40.74 to a high of 48.80. The Healthcare Providers & Services industry median Days Payable is 57.51. Miahelsa Holdings' value of 40.16 is 30.2% below this industry median. Based on the distribution chart, Miahelsa Holdings ranks #389 out of 605 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Miahelsa Holdings has a GF Score™ of 44/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Miahelsa Holdings' Days Payable compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Miahelsa Holdings ranks #389 out of 605 companies for Days Payable. This places Miahelsa Holdings in the lower half of its industry. The industry median Days Payable is 57.51. Miahelsa Holdings' value of 40.16 is 30.2% below this benchmark. Historically, Miahelsa Holdings' own Days Payable has ranged from 40.74 to 48.80 over the past decade. While the company's 10-year median is 42.40 vs. the industry median of 57.51, Miahelsa Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 57.51, based on 605 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Miahelsa Holdings's current Days Payable of 40.16 is 30.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Miahelsa Holdings and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 57.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Miahelsa Holdings's current Days Payable is 40.16, which is near median its own 10-year median of 42.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Miahelsa Holdings stock overvalued right now?
Based on GuruFocus' analysis, Miahelsa Holdings (TSE:7129) is currently considered Fairly Valued. The stock's GF Value™ is 円1,071.08, compared to a current price of 円1,147.00 — trading 7.1% above its estimated fair value. The current Days Payable is 40.16, which is near median its 10-year median of 42.40 and 30.2% below the Healthcare Providers & Services industry median of 57.51. Miahelsa Holdings' overall GF Score™ is 44/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Miahelsa Holdings (TSE:7129), the current Days Payable is 40.16 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Miahelsa Holdings (TSE:7129) Overvalued in 2026?
Based on GuruFocus' analysis, Miahelsa Holdings stock appears to be overvalued.
The current stock price of 円1,147.00 is trading 7.1% above its estimated GF Value™ of 円1,071.08.
GuruFocus considers Miahelsa Holdings to be Fairly Valued.
Key valuation signals for TSE:7129:
Days Payable: 40.16 (near median its 10-year median of 42.40)
GF Value™: 円1,071.08 vs. price of 円1,147.00 (7.1% above fair value)
Industry Position: 30.2% below the Healthcare Providers & Services median (#389 of 605)
No single metric tells the full story. See the TSE:7129 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Miahelsa Holdings Corp, along with its subsidiaries, operates in the following reportable segments: Pharmaceutical Business, Nursing Care Business, and Childcare Business. The majority of its revenue is generated from the Pharmaceuticals Business, which operates pharmaceutical dispensaries in Japan through Nissei Pharmacy and Miahelsa Pharmacy brands, and also offers home care services. The Nursing care business mainly provides housing, medical care, nursing care, prevention, and lifestyle support for elderly people, and the Childcare segment involves the operation of licensed childcare centers. In addition, the group also operates a food business providing food suitable for all ages, from infants to the elderly.
44GF Score
Get the complete analysis for TSE:7129
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7129 has been successfully added to your 
